Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

Clinical trial NCT06828796 · RECRUITING

Trial details

NCT number: NCT06828796
Sponsor: Northside Hospital, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Disease and Disorders Hematopoietic Cell Transplant

Start date: 2025-07-03
Primary completion: 2027-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.